Question Everything. See who's reporting it.

Virupaksha completes ₹104-crore acquisition of Vivin Drugs

Source: Times of India

The story in brief

Virupaksha Organics finalized its ₹104-crore acquisition of Vivin Drugs and Vivin Laboratories through NCLT approval. The deal merges both entities under Virupaksha, improving operational efficiency in Hyderabad. Virupaksha plans to launch its IPO next.

NEWXFree on Android and iPhone. Open in NEWX